A
AQST
Aquestive Therapeutics
4.10
1.15+38.98%After Hours: 4.130 +0.030 +0.73%19:59 02/02 EST
OPEN/PREV CLOSE4.000/2.950
TODAY RANGE3.790-4.390
VOL61.08M
MARKET CAP500.21M
52 WEEK RANGE2.120-7.55
AVG VOL (3M)4.87M
% TURNOVER50.07%
TURNOVER--
P/E (TTM)-5.8313
% RANGE20.34%
EPS(TTM)-0.7031
P/E(FORWARD)-6.3566
P/B-121.3018
BVPS-0.0338
DIVIDEND--
P/S6.51
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP464.49M
SHARES OUTSTANDING122.00M
NEXT EARNINGS03/03-03/09
FREE FLOAT113.29M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·9h ago
Aquestive jumps despite receiving FDA Complete Response Letter
Benzinga·12h ago
What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment?
Benzinga·13h ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·14h ago
Peakstone Realty Trust, Aquestive Therapeutics, Opera And Other Big Stocks Moving Higher On Monday
TipRanks·14h ago
Aquestive CRL from FDA ‘clearing event,’ says Oppenheimer
TipRanks·17h ago
FDA Issues Complete Response Letter on Anaphylm Application
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email : service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.